Evidence map›Paper›PMID 41951911›Full record

ArticleNature biotechnology2026

Sequence Display enables large-scale sequence-activity datasets for rapid protein evolution.

Linqi Cheng, Xinzhe Zheng, Shiyu Jason Jiang, Yu Hu, Yijie Liu, Kaiqiang Yang, Jinyan Rui, Haoxue Ding, Mengxi Zhang, Teng Yuan and 10 more

Abstract read
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Linqi Cheng *Department of Chemistry, Rice University, Houston, TX, USA.ORCID http://orcid.org/0000-0001-6520-1856
Xinzhe Zheng *Department of Chemistry, Rice University, Houston, TX, USA.
Shiyu Jason Jiang *Department of Chemistry, Rice University, Houston, TX, USA.ORCID http://orcid.org/0000-0001-9450-7379
Yu HuDepartment of Chemistry, Rice University, Houston, TX, USA.ORCID http://orcid.org/0009-0007-2217-1459
Yijie LiuDepartment of Chemistry, Rice University, Houston, TX, USA.ORCID http://orcid.org/0009-0002-3792-4947
Kaiqiang YangDepartment of Chemistry, Rice University, Houston, TX, USA.
Jinyan RuiDepartment of Chemistry, Johns Hopkins University, Baltimore, MD, USA.
Haoxue DingDepartment of Chemistry, Rice University, Houston, TX, USA.ORCID http://orcid.org/0000-0001-9351-9984
Mengxi ZhangDepartment of Chemistry, Rice University, Houston, TX, USA.
Teng YuanDepartment of Chemistry, Rice University, Houston, TX, USA.
Qianglan LuDepartment of Chemistry, Rice University, Houston, TX, USA.
Haoxin YeDepartment of Chemistry, Rice University, Houston, TX, USA.
Chen-Long LiDepartment of Chemistry, Rice University, Houston, TX, USA.ORCID http://orcid.org/0009-0005-9086-4332
Yiming GuoDepartment of Chemistry, Rice University, Houston, TX, USA.
Zuotong TianDepartment of Chemistry, Rice University, Houston, TX, USA.
Anna QinDepartment of Chemistry, Rice University, Houston, TX, USA.
Boyang ZhouDepartment of Chemistry, Rice University, Houston, TX, USA.
Kevin K YangMicrosoft Research, One Memorial Drive, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-9045-6826
Xiongyi HuangDepartment of Chemistry, Johns Hopkins University, Baltimore, MD, USA. xiongyi@jhu.edu.ORCID http://orcid.org/0000-0001-7156-8881
Han XiaoDepartment of Chemistry, Rice University, Houston, TX, USA. han.xiao@rice.edu.ORCID http://orcid.org/0000-0002-4311-971X

Funding

Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV InfectionR01AI165079 · NIAID · WISTAR INSTITUTE · PI ABDEL MOHSEN, MOHAMED, XIAO, HAN · 2021 to 2025
$3.1M
Engineering Proteins with Noncanonical Amino AcidsR35GM133706 · NIGMS · RICE UNIVERSITY · PI Han Xiao · 2019 to 2026
$2.9M
Modulation of Epigenetic Target in the Bone to Treat Breast Cancer MetastasisR01CA277838 · NCI · RICE UNIVERSITY · PI Han Xiao, Xiang Zhang · 2023 to 2026
$2.6M
NCI NIH HHS R01 CA277838NIAID NIH HHS R01 AI165079NIGMS NIH HHS R35 GM133706Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation Medical Research AwardU.S. Department of Defense (United States Department of Defense) HT9425-23-1-0494U.S. Department of Defense (United States Department of Defense) HT9425-25-1-0021U.S. Department of Defense (United States Department of Defense) W81XWH-21-1-0789U.S. Department of Health & Human Services | NIH | Center for Information Technology (Center for Information Technology, National Institutes of Health) R01-AI165079U.S. Department of Health & Human Services | NIH | Center for Information Technology (Center for Information Technology, National Institutes of Health) R01-CA277838U.S. Department of Health & Human Services | NIH | Center for Information Technology (Center for Information Technology, National Institutes of Health) R35-GM133706Welch Foundation C-1970
6 · The paper itself

Abstract

Engineering proteins with desired functions remains challenging and usually requires multiple rounds of screening and selection. Here, we present Sequence Display, a platform that generates large-scale protein sequence-activity datasets in a single round. Sequence Display enables multiplexed assessment of individual variant activity within a single experiment, offering a robust approach to mapping detailed sequence-function relationships. We demonstrate the platform's broad applicability by generating datasets for cytosine deaminase, uracil glycosylase inhibitor, aminoacyl-tRNA synthetase and a compact Cas9 nuclease. Integrating these datasets obtained from Sequence Display with pretrained protein language models, fine-grained, variant-specific activity landscapes can be constructed. We discovered several Cas9 variants with expanded protospacer-adjacent motif recognition and evolved aminoacyl-tRNA synthetase variants capable of recognizing different noncanonical amino acids. Together, this study establishes Sequence Display as a powerful tool for mapping protein activity landscapes and accelerating the discovery of optimized proteins for biological and medical applications.

Identifiers

PMID41951911
PMCPMC13097798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.